Once touted as a COVID-19 'game changer,' Paxlovid is now a question mark for clinicians
Early trials showed Paxlovid could be a 'game changer' to keep people out of hospital. Yet the COVID-19 landscape has changed since then, with most people now protected against serious illness thanks to vaccination or past infections. So who should get the Pfizer antiviral going forward?
Early trials showed Paxlovid could be a 'game changer' to keep people out of hospital. Yet the COVID-19 landscape has changed since then, with most people now protected against serious illness thanks to vaccination or past infections. So who should get the Pfizer antiviral going forward?
